Detalhe da pesquisa
1.
Correction: Adema et al. Heartbreaking Decisions: The Dogma and Uncertainties of Antimicrobial Therapy in Infective Endocarditis. Pathogens 2023, 12, 703.
Pathogens
; 13(3)2024 Feb 21.
Artigo
Inglês
| MEDLINE | ID: mdl-38535615
2.
Heartbreaking Decisions: The Dogma and Uncertainties of Antimicrobial Therapy in Infective Endocarditis.
Pathogens
; 12(5)2023 May 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37242373
3.
A Pharmacovigilance Analysis of Daptomycin Use Based on CLSI Susceptible Dose-Dependent Category.
Infect Dis Ther
; 12(9): 2295-2305, 2023 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-37751018
4.
Understanding and Application of Daptomycin-Susceptible Dose-Dependent Category for Enterococcus: A Mixed-Methods Study.
Open Forum Infect Dis
; 9(1): ofab611, 2022 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-35036465